Qube Research & Technologies LTD Atossa Therapeutics, Inc. Transaction History
Qube Research & Technologies LTD
- $91.4 Billion
- Q3 2025
A detailed history of Qube Research & Technologies LTD transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 138,643 shares of ATOS stock, worth $112,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
138,643
Previous 416,374
66.7%
Holding current value
$112,300
Previous $345,000
65.51%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ATOS
# of Institutions
75Shares Held
26.8MCall Options Held
79.5KPut Options Held
98.8K-
Black Rock Inc. New York, NY9.2MShares$7.45 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.08MShares$4.92 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2.95MShares$2.39 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.67MShares$1.35 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.55MShares$1.25 Million0.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $103M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...